Professor Andrew Pollard Interview re Oxford-AstraZeneca vaccine Part 2

The transcript discusses the roles of the government and manufacturers in vaccine delivery, ongoing research on vaccine efficacy and new variants, and the importance of developing a non-profit vaccine. It highlights the collaboration between Oxford University and AstraZeneca to ensure affordable vaccine distribution. The conversation also compares current efforts to past vaccine developments, emphasizing the pressure and significance of the work for humanity. Finally, it touches on public perceptions of science and scientists.

What is the role of the government in the mass vaccination process?

• To produce vaccine doses

• To manage the delivery of vaccines

• To develop new vaccine variants

• To conduct scientific research on vaccines

Why was it important for the University of Oxford to develop a not-for-profit vaccine?

• To fulfill its mission of accessibility and affordability

• To gain international recognition

• To increase the university's profits

• To compete with other vaccine manufacturers

Which company partnered with the University of Oxford to ensure the vaccine was not-for-profit?

• Moderna

• Pfizer

• Johnson & Johnson

• AstraZeneca

How does the current vaccine development effort compare to past experiences like the swine flu?

• It is less challenging

• It involves different scientific principles

• It is handled by the same team

• It has greater pressure due to its importance

What is a common misconception about scientists during breakthroughs?

• They often shout 'Eureka!'

• They always wear white coats

• They work alone

• They are not under pressure